Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,711 | 701 | 99.3% |
| Education | $73.60 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,997 | 133 | $0 (2024) |
| Novo Nordisk Inc | $1,085 | 80 | $0 (2024) |
| PFIZER INC. | $753.90 | 58 | $0 (2024) |
| Amgen Inc. | $629.03 | 34 | $0 (2024) |
| Lilly USA, LLC | $621.27 | 48 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $571.23 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $442.68 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $376.22 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $376.05 | 39 | $0 (2024) |
| Mylan Specialty L.P. | $359.02 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,780 | 179 | ABBVIE INC. ($589.21) |
| 2023 | $2,628 | 174 | ABBVIE INC. ($609.56) |
| 2022 | $1,835 | 126 | Novo Nordisk Inc ($393.60) |
| 2021 | $504.23 | 22 | Biohaven Pharmaceuticals, Inc. ($135.39) |
| 2020 | $322.52 | 21 | Janssen Pharmaceuticals, Inc ($49.20) |
| 2019 | $1,448 | 103 | Amgen Inc. ($220.39) |
| 2018 | $419.62 | 22 | AbbVie, Inc. ($176.52) |
| 2017 | $847.23 | 59 | Allergan Inc. ($127.21) |
All Payment Transactions
706 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: VACCINES | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Azurity Pharmaceuticals, Inc. | EDARBI (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: ANTIBIOTIC | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: VACCINES | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,027 | 1,321 | $285,356 | $110,026 |
| 2022 | 14 | 871 | 1,171 | $232,423 | $98,983 |
| 2021 | 14 | 936 | 1,277 | $232,072 | $105,658 |
| 2020 | 12 | 1,012 | 1,286 | $224,607 | $86,163 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 318 | 556 | $135,108 | $43,854 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 254 | 254 | $62,992 | $30,919 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 166 | 216 | $37,152 | $11,858 | 31.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 41 | 41 | $21,730 | $11,565 | 53.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 50 | 51 | $7,476 | $3,658 | 48.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 17 | $6,596 | $2,495 | 37.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $5,831 | $2,062 | 35.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 50 | 51 | $2,952 | $1,459 | 49.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 41 | 41 | $2,296 | $1,173 | 51.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 13 | 13 | $806.00 | $399.68 | 49.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $1,590 | $380.70 | 23.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 15 | 15 | $555.00 | $129.48 | 23.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 31 | 34 | $272.00 | $74.80 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 303 | 556 | $119,323 | $44,487 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 219 | 219 | $49,962 | $27,139 | 54.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 169 | $25,638 | $9,765 | 38.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 21 | 21 | $10,618 | $5,848 | 55.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 45 | 45 | $6,300 | $3,084 | 49.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 12 | $4,392 | $1,872 | 42.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $3,477 | $1,755 | 50.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $3,829 | $1,639 | 42.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 46 | 46 | $2,576 | $1,239 | 48.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,426 | $890.78 | 26.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 24 | 24 | $1,128 | $649.06 | 57.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 13 | $1,138 | $468.96 | 41.2% |
About Dr. Vincent Lang, MD
Dr. Vincent Lang, MD is a Family Medicine healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083672620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vincent Lang, MD has received a total of $10,785 in payments from pharmaceutical and medical device companies, with $2,780 received in 2024. These payments were reported across 706 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($10,711).
As a Medicare-enrolled provider, Lang has provided services to 3,846 Medicare beneficiaries, totaling 5,055 services with total Medicare billing of $400,831. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Louisville, KY
- Active Since 05/03/2006
- Last Updated 12/08/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1083672620
Products in Payments
- UBRELVY (Drug) $687.14
- VRAYLAR (Drug) $662.70
- NURTEC ODT (Drug) $393.97
- JARDIANCE (Drug) $344.70
- ELIQUIS (Drug) $319.49
- XARELTO (Drug) $309.96
- YUPELRI (Drug) $305.20
- Ozempic (Drug) $288.71
- Rybelsus (Drug) $285.14
- ENTRESTO (Drug) $283.33
- VOQUEZNA (Drug) $274.03
- Aimovig (Biological) $266.28
- MOUNJARO (Drug) $216.45
- TRELEGY ELLIPTA (Drug) $210.05
- FARXIGA (Drug) $201.31
- JANUVIA (Drug) $193.88
- Kerendia (Drug) $185.05
- Cologuard Collection Kit (Device) $183.77
- EMGALITY (Drug) $172.25
- COMIRNATY (Biological) $170.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Louisville
Christopher Rhyne, M.d, M.D
Family Medicine — Payments: $701,120
Dr. Suraj Gathani, M.d, M.D
Family Medicine — Payments: $64,592
Michael Pendleton, Md, MD
Family Medicine — Payments: $29,425
Mandy Whitt, M.d, M.D
Family Medicine — Payments: $23,888
Dr. James Wright, M.d, M.D
Family Medicine — Payments: $21,045
Rosenberg Reyes, M.d, M.D
Family Medicine — Payments: $18,853